Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors

American Journal of Surgical Pathology

Volumn 25, Issue 1, 2001, Pages 51-57

  King, Roy ^a   Googe, Paul B ^a,b,c   Weilbaecher, Katherine N ^d   Mihm Jr , Martin C ^e   Fisher, David E ^d  

^a Knoxville Dermatopathology Laboratory   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Melanocytic lesions; Melanoma; Microphthalmia gene; Mitf antibody

Indexed keywords

ANTIBODY; GENE PRODUCT; MITF ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MI; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; MICROPHTHALMIA; NEVUS; PROTEIN EXPRESSION; SKIN TUMOR; SPINDLE CELL CARCINOMA;

DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTES; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NEOPLASM PROTEINS; NEVUS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0035192629     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200101000-00005     Document Type: Article

References (43)

1. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases
2. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia product and role of the initiator
3. Microphthalmia gene product as a signal transducer in cAMP induced differentiation of melanocytes
4. Breast carcinoma positive for melanoma marker (HMB-45)
5. Clear cell ('sugar') tumor of the lung is a lesion strictly related to angiomyolipoma - The concept of a family of lesions characterized by the presence of perivascular epithelioid cells (PEC)
6. The perivascular epithelioid cell and related lesions
7. Desmoplastic melanoma
8. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
9. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors
10. Melan-A. A new melanocytic differentiation marker
11. Lymphangioleiomyomatosis and angiomyolipoma: Closely related entities characterized by hamartomatous proliferation of HMB-45 positive smooth muscle
12. Direct regulation of nacre, a zebra fish MITF homolog required for pigment cell formation, by the Wnt pathway
13. S-100 protein immunoreactivity in poorly differentiation carcinomas: Immunohistochemical comparison with malignant melanoma
14. Comparison of melanoma antigen recognized by T-cells (MART-1) to HMB-45. Additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor
15. S-100 protein expression by primary and metastatic adenocarcinomas
16. MAP kinase links the transcription factor microphthalmia to c-Kit signalling in melanocytes
17. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family
18. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic helix-loop-helix zipper protein
19. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis
20. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1
21. Melanocyte-associated markers A103, T311, HMB-45 and D5 in angiomyolipomas - A comparison
22. Expression of melanocyte-associated markers GP-100 and melan-A/MART-1 in angiomyolipomas. An immunohistochemical and RT-PCR analysis
23. Cutaneous leiomyosarcoma
24. Atypical fibroxanthomas of the skin
25. Microphthalmia transcription factor: A sensitive and specific melanocytic marker for melanoma diagnosis
26. A mouse model for vitiligo
27. Desmoplastic and spindlecell malignant melanoma
28. Clear cell tumor and angiomyolipoma
29. Melanocyte-marker HMB-45 is regularly expressed in angiomyolipoma of the kidney
30. αMSH signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome
31. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
32. Stabilization of betacatenin by genetic defects in melanoma cell lines
33. Immunohistochemistry in the evaluation of melanocytic tumors
34. S100 protein: Is it useful as a tumour marker in diagnostic immunocytochemistry?
35. Spindle cell and pleomorphic neoplasms of the skin. A clinicopathological and immunohistochemical study of 30 cases, with emphasis on 'atypical fibroxanthomas'
36. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas
37. S100 protein in soft tissue tumours derived from Schwann cells and melanocytes
38. Molecular basis of mouse microphthalmia (mi) mutations helps explain their development and phenotypic consequences
39. Angiomyolipomas: The nature and expression of the HMB-45 antigen
40. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene
41. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TFE3
42. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene
43. Melanoma associated antigens in tumors of the nervous system: An immunohistochemical study with the monoclonal antibody HMB-45